None listed
Conditions
Interventions
Drug : In the case of insufficient pain control of more than 4 points of VAS while taking diabetic neuropathy drugs, or adverse reactions related to the drug such as dizziness, headache, drowsiness, s
Sponsors
Seoul National University Bundang Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. adults over 19 years of age 2. Those diagnosed with diabetes (recruitment regardless of type 1 and type 2 diabetes) 3. a person with diabetic neuropathy 4. Those who have experienced drug-related side effects when administering Pregabalin, TCA, and duloxetine 5. If the medication mentioned in No. 4 is not administered or side effects are not felt at the time of administration, a person with pain of at least 4 VAS points
Exclusion criteria
Exclusion criteria: 1. a pregnant woman 2. Those who are scheduled to undergo surgery and inpatient treatment within one month (excluding hospitalization for diabetes education) 3. A person who has undergone chemotherapy within the last three years or plans to receive it 4. Those who have a history of taking prednisolone more than 10 mg per day within the last 3 months or are taking it 5. Those who have uncontrolled thyroid dysfunction 6. a person undergoing renal replacement treatment, including dialysis 7. A person who has a liver disease of Child-pugh class C or higher 8. persons who have difficulty in independent living and self-management
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| total symptom score (TSS) | — |
Secondary
| Measure | Time frame |
|---|---|
| MNSI-Q, MNSI-PE;Visual Analog Scale;DN-4 pain questionnaire;Autonomic Nervous System Abnormal Score, ;SUDOSCAN | — |
Countries
Korea, Republic of
Contacts
Public ContactYoung Seon Ko
Seoul National University Bundang Hospital
Outcome results
None listed